The importance of BDNF and RAGE in diabetes-induced dementia

Pharmacol Res. 2020 Oct:160:105083. doi: 10.1016/j.phrs.2020.105083. Epub 2020 Jul 15.

Abstract

Diabetes-induced dementia is an emerging neurodisorder all over the world. The prevalence rates of dementia and diabetes have been gradually increasing worldwide. Diabetes has been known to lead to oxidative stress, inflammation aggravation, and hyperglycemia conditions in the brain. Various diabetic implications cause the lower secretion of brain-derived neurotrophic factor (BDNF) and the increase of receptor for advanced glycation end products (RAGE), ultimately leading to both cerebrovascular dysfunction and cognitive decline. Here, we summarized the significant evidences highlighting the specific mechanisms between BDNF and RAGE and cerebrovascular dysfunction and memory function and how these relate to diabetes-induced dementia. Especially, we review that the association between BDFN and RAGE in neuroinflammation, the reduction of long-term potentiation, and the vascular implications in brain.

Keywords: Brain-derived neurotrophic factor (BDNF); Cerebrovascular dysfunction; Cognitive decline; Diabetes-induced dementia; Receptor for advanced glycation end products (RAGE).

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Blood Glucose / metabolism
  • Brain / blood supply*
  • Brain-Derived Neurotrophic Factor / metabolism*
  • Cerebral Arteries / metabolism*
  • Cerebral Arteries / physiopathology
  • Cerebrovascular Circulation
  • Cognition*
  • Dementia, Vascular / epidemiology
  • Dementia, Vascular / metabolism*
  • Dementia, Vascular / physiopathology
  • Dementia, Vascular / psychology
  • Diabetes Complications / epidemiology
  • Diabetes Complications / metabolism*
  • Diabetes Complications / physiopathology
  • Diabetes Complications / psychology
  • Glycation End Products, Advanced / metabolism
  • Humans
  • Long-Term Potentiation
  • Memory
  • Receptor for Advanced Glycation End Products / metabolism*
  • Risk Factors
  • Signal Transduction

Substances

  • Blood Glucose
  • Brain-Derived Neurotrophic Factor
  • Glycation End Products, Advanced
  • Receptor for Advanced Glycation End Products